ÂÜÀòÂÒÂ×

Daryl Drummond is a highly experienced scientific leader currently serving as Chief Scientific Officer at Akagera Medicines, Inc. since July 2019. Previously, Daryl held the position of Interim Head of Research & Development at Tidal Therapeutics, a Sanofi Company, from October 2019 to December 2023, and served as a Senior Biotech Consultant specializing in nanotherapeutics development from June 2019 to August 2023. From June 2014 to July 2019, Daryl was the Head of Research and Senior Vice President at Merrimack. Daryl also held leadership roles at Merrimack Pharmaceuticals and Hermes Biosciences, focusing on drug discovery and liposome research. Daryl's academic credentials include a Ph.D. in Biochemistry and a second Ph.D. in Chemistry from Indiana University Bloomington, a Post Doctorate in Nanotechnology and Drug Delivery from California Pacific Medical Center, and an Executive Education program in Leadership and Strategy from Harvard Business School.